Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock - PubMed (original) (raw)

. 2003 Nov;24(11):1747-52.

doi: 10.1016/j.peptides.2003.07.027.

Oscar Cirioni, Roberto Ghiselli, Federico Mocchegiani, Claudio Viticchi, Fiorenza Orlando, Giuseppina D'Amato, Maria Simona Del Prete, Wojciech Kamysz, Jerzy łLukasiak, Vittorio Saba, Giorgio Scalise

Affiliations

Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock

Andrea Giacometti et al. Peptides. 2003 Nov.

Abstract

The therapeutic efficacy of protegrin peptide IB-367 was investigated in three rat models of septic shock: (i) rats injected intraperitoneally with 1mg Escherichia coli 0111:B4 lipopolysaccharide, (ii) rats given an intraperitoneal injection of 2 X 10(10) CFU of E. coli ATCC 25922, and (iii) rats in which intra-abdominal sepsis was induced via cecal ligation and puncture. All animals were randomized to receive parenterally isotonic sodium chloride solution, 1mg/kg of IB-367, 60mg/kg piperacillin and 1mg/kg of IB-367 plus 60mg/kg piperacillin. The peptide demonstrated lower level of antimicrobial activity than piperacillin, nevertheless it exhibited the dual properties of antimicrobial and antiendotoxin agent. Finally IB-367 and piperacillin association showed to be the most effective therapeutic approach.

PubMed Disclaimer

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources